PNTG
The Pennant Group, Inc. · Healthcare · Medical - Care Facilities
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -17.6% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 82 | +2 | 17.44M | $643.76M | +9 | −6 |
| Q1 2026 | 82 | +1 | 17.11M | $521.38M | +4 | −3 |
| Q4 2025 | 81 | +1 | 18.52M | $521.75M | +2 | −1 |
| Q3 2025 | 19 | 0 | 10.21M | $257.46M | +1 | −1 |
| Q2 2025 | 16 | -1 | 11.14M | $332.63M | +1 | −2 |
| Q1 2025 | 14 | +3 | 2.52M | $63.50M | +3 | n/a |
| Q4 2024 | 11 | -2 | 2.73M | $72.43M | +1 | −3 |
| Q3 2024 | 12 | +2 | 1.68M | $60.08M | +2 | n/a |
| Q2 2024 | 10 | n/a | 1.92M | $44.57M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 2.66M | +0.3% | $67.04M | 0.0% | ▲ Add | 2 | SEC ↗ ×14 |
| 2 | The Vanguard Group ✦ (passive) | 1.97M | -6.1% | $49.63M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | Fidelity (FMR) ✦ | 850.55K | -77.5% | $21.45M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 4 | Geode Capital Management ✦ (passive) | 816.17K | -2.0% | $20.59M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (passive) | 791.50K | +1.3% | $19.96M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Goldman Sachs Group ✦ | 497.94K | n/a | $12.56M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 490.59K | n/a | $12.37M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 8 | Wellington Management ✦ | 478.04K | +36.1% | $12.06M | 0.0% | ▲ Add | 6 | SEC ↗ ×3 |
| 9 | D. E. Shaw & Co. ✦ | 319.20K | +72.4% | $8.05M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 10 | JPMorgan Chase ✦ | 261.44K | n/a | $6.59M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 11 | Marshall Wace ✦ | 229.29K | New | $5.78M | 0.0% | New | 1 | SEC ↗ ×2 |
| 12 | Citadel Advisors ✦ | 223.88K | +640.0% | $5.65M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 13 | Renaissance Technologies ✦ | 183.70K | +593.2% | $4.63M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | Adage Capital Partners ✦ | 139.61K | +310.6% | $3.52M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 120.85K | -31.5% | $3.05M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | Millennium Management ✦ | 119.96K | +12.0% | $3.03M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 40.47K | +2.6% | $1.02M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 11.15K | -17.0% | $281,152 | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 19 | GAMCO Investors ✦ | 8.12K | 0.0% | $204,711 | 0.0% | Held | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $5.78M | 0.0% |
Exited
| Arrowstreet Capital | $805,234 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 182 holders, 28.77M shares, $793.32M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 1.39K sh · $53,661
Officer · 4.29K sh · $165,067
Officer · 1.39K sh · $53,700
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology